Gentian Diagnostics AS (OSL:GENT) Interest Expense: kr-5.3 Mil (TTM As of Jun. 2026)


OSL:GENT Gentian Diagnostics AS OSL:GENT
74 GF Score
Price kr38.40
GF Value kr59.17
Valuation Significantly Undervalued
View Full Analysis

What is Gentian Diagnostics AS Interest Expense?

Gentian Diagnostics AS OSL:GENT -2.04% 74 Interest Expense is kr-5.3 Mil as of Jun. 2026. GuruFocus rates OSL:GENT with a GF Score™ of 74/100 and a GF Value™ of kr59.17 (Significantly Undervalued).

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Gentian Diagnostics AS's interest expense for the three months ended in Jun. 2026 was kr -0.8 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2026 was kr-5.3 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Gentian Diagnostics AS's Operating Income for the three months ended in Jun. 2026 was kr 5.9 Mil. Gentian Diagnostics AS's Interest Expense for the three months ended in Jun. 2026 was kr -0.8 Mil. Gentian Diagnostics AS's Interest Coverage for the quarter that ended in Jun. 2026 was 7.33. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Gentian Diagnostics AS  (OSL:GENT) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Gentian Diagnostics AS's Interest Expense for the three months ended in Jun. 2026 was kr-0.8 Mil. Its Operating Income for the three months ended in Jun. 2026 was kr5.9 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2026 was kr16.8 Mil.

Gentian Diagnostics AS's Interest Coverage for the quarter that ended in Jun. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Jun. 2026 )/Interest Expense (Q: Jun. 2026 )
=-1*5.91/-0.806
=7.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Gentian Diagnostics AS Interest Expense Historical Data

* Premium members only.

The historical data trend for Gentian Diagnostics AS's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gentian Diagnostics AS Interest Expense Chart

Gentian Diagnostics AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.38 -1.26 -0.80 -0.66 -0.67

Gentian Diagnostics AS Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.11 -1.30 -0.83 -2.42 -0.81
OSL:GENT
74GF Score
Gentian Diagnostics AS OSL:GENT
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gentian Diagnostics AS Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-5.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of kr-5.3 Mil mean?
Gentian Diagnostics AS (OSL:GENT) has a Interest Expense of kr-5.3 Mil as of Jun. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Gentian Diagnostics AS and its competitors.
Is Gentian Diagnostics AS's Interest Expense too high?
Gentian Diagnostics AS's current Interest Expense is kr-5.3 Mil. Overall, Gentian Diagnostics AS has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Gentian Diagnostics AS's Interest Expense compare to ABT and SYK?
Gentian Diagnostics AS's Interest Expense of kr-5.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Devices & Instruments company?
A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Gentian Diagnostics AS and its competitors. Gentian Diagnostics AS's current Interest Expense is kr-5.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gentian Diagnostics AS stock overvalued right now?
Based on GuruFocus' analysis, Gentian Diagnostics AS (OSL:GENT) is currently considered Significantly Undervalued. The stock's GF Value™ is kr59.17, compared to a current price of kr38.40 — trading 35.1% below its estimated fair value. The current Interest Expense is kr-5.3 Mil. Gentian Diagnostics AS's overall GF Score™ is 74/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Gentian Diagnostics AS (OSL:GENT), the current Interest Expense is kr-5.3 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gentian Diagnostics AS (OSL:GENT) Overvalued in 2026?

Based on GuruFocus' analysis, Gentian Diagnostics AS stock appears to be undervalued. The current stock price of kr38.40 is trading 35.1% below its estimated GF Value™ of kr59.17. GuruFocus considers Gentian Diagnostics AS to be Significantly Undervalued.

Key valuation signals for OSL:GENT:

  • Interest Expense: kr-5.3 Mil
  • GF Value™: kr59.17 vs. price of kr38.40 (35.1% below fair value)
  • GF Score™: 74/100

No single metric tells the full story. See the OSL:GENT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gentian Diagnostics AS Business Description

Other Exchanges GENTOo:Sweden6FK:Germany
Address Bjornasveien 5, Moss, NOR, 1596
Gentian Diagnostics AS operates as a medical diagnostics company in Norway. It develops and produces in vitro diagnostic reagents (IVD) for medical diagnostics and research. Its portfolio and pipeline of reagents span areas such as inflammation, severe infections, kidney diseases, heart failure, and veterinary healthcare. The company's product portfolio includes the Gentian Cystatin C Immunoassay, the GCAL circulating calprotectin immunoassay (IVDR), the Gentian Retinol Binding Protein (RBP), and the Gentian Canine CRP, among others. Geographically, it generates a majority of its revenue from Europe, followed by Asia and the United States of America.
74GF Score

Get the complete analysis for OSL:GENT

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr38.40
Price
kr59.17
GF Value